NPI: 1417252867 · YUBA CITY, CA 95991 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/17/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/17/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,465 | $704K |
| 2019 | 26,817 | $1.07M |
| 2020 | 19,420 | $793K |
| 2021 | 9,275 | $714K |
| 2022 | 13,293 | $624K |
| 2023 | 13,086 | $681K |
| 2024 | 583 | $1.08M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 51,185 | 4,414 | $5.26M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 231 | 229 | $196K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,772 | 1,779 | $117K |
| A4657 | Syringe, with or without needle, each | 2,961 | 1,360 | $61K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,820 | 1,048 | $18K |
| 0250 | 3,377 | 198 | $6K | |
| J1756 | Injection, iron sucrose, 1 mg | 6,684 | 1,961 | $4K |
| 83540 | 640 | 599 | $212.00 | |
| 90662 | 82 | 77 | $73.40 | |
| 90674 | 95 | 93 | $62.68 | |
| G0008 | Administration of influenza virus vaccine | 178 | 175 | $43.46 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 286 | 179 | $19.59 |
| 85045 | 566 | 307 | $0.00 | |
| 85048 | 1,211 | 1,130 | $0.00 | |
| 83970 | 786 | 736 | $0.00 | |
| 85041 | 1,226 | 1,145 | $0.00 | |
| 82108 | 199 | 186 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 466 | 408 | $0.00 |
| 82728 | 645 | 602 | $0.00 | |
| 83550 | 491 | 451 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 23 | 23 | $0.00 |
| 82607 | 15 | 15 | $0.00 |